Clinical Updates
Drug approvals, guideline changes, and treatment advances
Neurotensin Receptor 2 Activation Shows Promise in Preventing Heart Failure Progression
Activation of neurotensin receptor 2 in preclinical models significantly reduced pathological changes in heart tissue, suggesting a novel therapeutic target…
Editor's Top Picks
Innate Immune Strength Paradoxically Linked to Worse Flu Symptoms in Controlled Challenge Study
A controlled human influenza challenge study in Nature Medicine reveals that heightened innate immune cell responsiveness paradoxically correlates with increased…
Submit Your Paper →
More form Clinical Updates
Would Hunters Accept a Lyme Disease Vaccine? New Research Reveals Hesitation Among High-Risk Groups
As tick populations reach decade-high levels, new research reveals vaccine hesitancy among hunters and outdoor…
AI agents AMIE and MIRA show promise in clinical decision-making, but clinical deployment remains years away
Two agentic AI models—AMIE and MIRA—have demonstrated potential in clinical decision-making across diagnosis, treatment, and…
AI Agent Matches Hematology Experts in Cancer Treatment Decisions, Nature Medicine Study Shows
A case-grounded AI agent has demonstrated high concordance with hematology tumor board decisions across retrospective,…
MHRA Safety Roundup: June 2026 — Key Drug and Device Alerts for Clinicians
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published its June 2026 safety…
Onsite Training and Mentorship Accelerates Childhood Cancer Diagnosis in Ethiopia
A multilevel training and mentorship program significantly improved childhood cancer diagnosis in Northwest Ethiopia, addressing…